CureVac N.V. Target price 2024 - Analyst rating & recommendation
CureVac N.V. Classifications & Recommendation:
CureVac N.V. Target price
| Target price | $8.60 |
| Course | $3.36 |
| Price potential |
155.92%
register free of charge
|
| Number of estimates | 7 |
|
7 Analysts have issued a price target CureVac N.V. 2025 .
The average CureVac N.V. target price is $8.60.
This is
155.92%
register free of charge
$17.83
430.65%
register free of charge
$2.57
23.65%
register free of charge
|
|
| A rating was issued by 8 analysts: 4 Analysts recommend CureVac N.V. to buy, 3 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst estimates: Analysts believe that the CureVac N.V. share has an average upside potential 2025 of
155.92%
register free of charge
|
Sales and margin forecast 2024, 2025 to 2028
| Dec '23 |
2024 Forecast |
|
|---|---|---|
| Turnover Million $ | 58.12 | 53.91 |
| 17.98% | 7.24% | |
| EBITDA margin | -473.92% | -372.94% |
| 23.15% | 21.31% | |
| Net margin | -490.15% | -467.23% |
| 12.20% | 4.68% |
8 Analysts have issued a sales forecast CureVac N.V. 2024 . The average CureVac N.V. sales estimate is
This results in the following potential growth figures:
4 Analysts have issued an CureVac N.V. EBITDA forecast 2024. The average CureVac N.V. EBITDA estimate is
This results in the following potential growth figures and future EBITDA margins:
5 CureVac N.V. Analysts have issued a net profit forecast 2024. The average CureVac N.V. net profit estimate is
This results in the following potential growth figures and future net margins:
Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 to 2028
| Dec '23 |
2024 Forecast |
|
|---|---|---|
| Earnings per share $ | -1.27 | -1.12 |
| 7.97% | 11.81% | |
| P/E ratio | negative | |
| EV/Sales | 8.78 |
5 Analysts have issued a CureVac N.V. forecast for earnings per share. The average CureVac N.V. <a href=/blog/eps>EPS is
This results in the following potential growth figures and future valuations:
Based on analysts' sales estimates for 2024, the CureVac N.V. share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of
This results in the following potential growth figures and future valuations:
Discover more stocks with a high price target
Register for free
StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.
